Suppr超能文献

新型冠状病毒肺炎的长期肾脏后果。新出现的证据及未解决的问题。

Long-term renal consequences of COVID-19. Emerging evidence and unanswered questions.

作者信息

Lang S M, Schiffl H

机构信息

Klinik für Innere Medizin V, Universitätsklinikum FSU Jena, Am Klinikum 1, 07747, Jena, Germany.

Medizinische Klinik und Poliklinik IV, Klinikum der LMU München, Munich, Germany.

出版信息

Int Urol Nephrol. 2025 Jun 20. doi: 10.1007/s11255-025-04616-w.

Abstract

PURPOSE

COVID-19 infection is associated with a high burden of acute or acute on chronic kidney injury (AKI), particularly in critically ill patients. Given the large numbers of COVID-19 survivors, characterization of long-term adverse kidney effects of COVID-19 have important implications for post-COVID-19 care.

METHODS

This narrative review provides a summary of epidemiologic evidence for post-COVID kidney disorders.

RESULTS

Precise post-COVID renal data are scarce. The true burden of long-COVID chronic kidney disease (CKD) remains unknown owing to under-recognition, under-diagnosis, clinical heterogeneity of patients, incomplete follow-up, and temporal trends in critical COVID-19 disease across waves of the pandemic. Collectively, the few well-designed studies assessing the impact of long-COVID on kidney health found that the overwhelming majority of patients with normal renal function at admission and without AKI during acute COVID-19 disease preserved kidney function. Post-infection kidney function trajectories of patients who experience a loss of renal function vary. Kidney function may decline gradually even in non-hospitalized patients, hospitalized patients may experience a rapid loss of kidney function 6-12 months after COVID-19 diagnosis or hospital discharge resulting from AKI during the acute phase of the disease. End-stage renal disease may occur after non-recovery from AKI and rapid progression of pre-existing CKD. Multiple mechanisms may trigger post-COVID CKD including maladaptive repair after AKI, or progression of renal lesions of systemic co-morbidities, persistence of the virus and dysregulation of inflammatory cytokines.

CONCLUSIONS

The COVID-19 pandemic has significantly impacted and may continue to have an impact on kidney health. Patients at risk have a higher propensity to develop critical COVID-19 disease. Post-COVID-19 care must pay close attention to renal function in patients discharged from hospital.

摘要

目的

新型冠状病毒肺炎(COVID-19)感染与急性肾损伤或慢性肾脏病急性加重(AKI)的高负担相关,尤其是在危重症患者中。鉴于大量COVID-19幸存者,了解COVID-19的长期肾脏不良影响对COVID-19后护理具有重要意义。

方法

本叙述性综述总结了COVID-19后肾脏疾病的流行病学证据。

结果

精确的COVID-19后肾脏数据稀缺。由于认识不足、诊断不足、患者临床异质性、随访不完整以及大流行各波次中重症COVID-19疾病的时间趋势,长期COVID慢性肾脏病(CKD)的真实负担仍不清楚。总体而言,少数评估长期COVID对肾脏健康影响的精心设计研究发现,绝大多数入院时肾功能正常且在急性COVID-19疾病期间无AKI的患者保留了肾功能。肾功能丧失患者感染后的肾功能轨迹各不相同。即使在非住院患者中,肾功能也可能逐渐下降,住院患者在COVID-19诊断或出院后6至12个月可能因疾病急性期的AKI而迅速丧失肾功能。急性肾损伤未恢复和原有慢性肾脏病快速进展后可能发生终末期肾病。多种机制可能引发COVID-19后慢性肾脏病,包括急性肾损伤后的适应性修复不良、全身性合并症的肾脏病变进展、病毒持续存在以及炎性细胞因子失调。

结论

COVID-19大流行对肾脏健康产生了重大影响,且可能继续产生影响。高危患者发生重症COVID-19疾病的倾向更高。COVID-19后护理必须密切关注出院患者的肾功能。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验